Physician profile
Monica Mccrary
NPI 1710042064
$1,672.37
in general payments reported to CMS, 2019-2025
19 companies · $506 in 2025
The $506 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $78.90 · 2021: $154 · 2022: $223 · 2023: $325 · 2024: $144 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $903 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $903.03 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $400.51 | 2021-2025 | Otezla, Otezla |
| Incyte Corporation | $251.25 | 2022-2024 | Opzelura |
| Janssen Biotech, INC. | $225.71 | 2019-2025 | Tremfya, Simponi, Stelara |
| Abbvie INC. | $179.13 | 2019-2020 | |
| Leo Pharma INC. | $102.21 | 2019-2025 | Adbry, Anzupgo |
| Galderma Laboratories, L.P. | $89.98 | 2021-2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $62.36 | 2019-2025 | Dupixent |
| Almirall LLC | $58.76 | 2022-2025 | Seysara |
| Lilly USA, LLC | $58.28 | 2020-2025 | Ebglyss, Taltz |
| Sun Pharmaceutical Industries INC. | $55.34 | 2019-2023 | Ilumya |
| Genzyme Corporation | $36.80 | 2020-2022 | |
| Organon LLC | $27.87 | 2025 | Vtama |
| Allergan, INC. | $24.93 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.70 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $19.62 | 2023 | Sotyktu |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $15.94 | 2025 | |
| Strata Skin Sciences, INC. | $15.86 | 2025 | Xtrac |
| Mission Pharmacal Company | $12.50 | 2019 | |
| Journey Medical Corporation | $11.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Mccrary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.